Clinical Trials Browser

Recruiting × INDUSTRY × sugemalimab × Clear all

NCT06097962 2026-05-20

Safety and Efficacy of NK510 to Treat NSCLC

Phase EARLY_PHASE1 Recruiting

Pleural Effusion, Malignant

NCT06617416 2025-03-12

A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung